IPO backed by big pockets at 20c, maybe 15c with discount. A lot of progress made and new techs added but due to senseless general bio-tech sell off totally undervalued. 90+c is a 5 year outlook, not BS as one poster here wants to establish. In the US the MC would be about USD 1b based on recent deals made for pre-clinical drugs less advanced than CHM's.
GLTA
Ann: Response to ASX Query, page-4
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.76M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.8¢ | $21.93K | 1.168M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 1519165 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1262067 | 4 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| CHM (ASX) Chart |